FDA warns of rare 'eye stroke' risk from GLP-1 drugs ...Middle East

The Hill - News
FDA warns of rare eye stroke risk from GLP-1 drugs
The Food and Drug Administration (FDA) ‌on Monday required pharmaceutical companies to warn patients and healthcare providers of a potential increased risk of a serious eye condition associated with the use of GLP-1 drugs for weight loss and diabetes.  Non-arteritic anterior ischemic optic neuropathy (NAION), often referred to as an "eye stroke,” is a rare condition...

Hence then, the article about fda warns of rare eye stroke risk from glp 1 drugs was published today ( ) and is available on The Hill ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA warns of rare 'eye stroke' risk from GLP-1 drugs )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News